A Phase 1, Non‑Randomized, Open‑Label, Single‑Dose, Single Period Study With Non‑Pharmacologically Active Dose Of PF‑06427878 To Characterize Pharmacokinetics Following Intravenous Administration In Healthy, Adult, Male Subjects

Trial Profile

A Phase 1, Non‑Randomized, Open‑Label, Single‑Dose, Single Period Study With Non‑Pharmacologically Active Dose Of PF‑06427878 To Characterize Pharmacokinetics Following Intravenous Administration In Healthy, Adult, Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Dec 2014

At a glance

  • Drugs PF 6427878 (Primary)
  • Indications Hyperlipidaemia
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 17 Dec 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
    • 29 Oct 2014 Planned End Date changed from 30 Nov 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
    • 16 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top